Report ID: 10078919 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Pediatric Healthcare Industry was valued at USD 123.7 Billion in the year 2017. Global Pediatric Healthcare Industry is further estimated to grow at a CAGR of 3.8% from 2019 to reach USD 166.96 Billion by the year 2025. The North America region holds the highest Industry share in 2017 and the Asia Pacific is considered as the fastest growing Industry in the forecasted period. At a country level, US, China and the U.S. are projected to grow strongly in the coming years due to increasing density of population.
Major market players in Pediatric Healthcare Industry are Pfizer Inc., GlaxoSmithKline plc., Merck & Co. Inc, AstraZeneca plc., Boehringer Ingelheim GmbH, Gilead Sciences Inc., Sanofi S.A.,
Pediapharm Inc., Novartis AG, Eisai Co. Ltd., Mylan N.V., and brief overview of 9 companies is also provided in the report. Rising research and development expenses are catering to changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
SWOT Analysis of Pediatric Healthcare Industry:
Strength:
Changes in lifestyle
Rising awareness towards pediatric disorders
Weakness:
High cost
Opportunities:
Advancement in technology
Threats:
Inadequate regulatory funding
The Drug Class segment is divided as Antibiotics, Analgesics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Anti-hypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipyschotics and Others in which the anti-biotics segment contributes to the highest share in the Industry. Antibiotics are extensively utilized, particularly for pediatric patients, due to their efficacy in treating bacterial infections.
Pediatric Healthcare Industry Segmentation:
By Drug Class
• Antibiotics
• Analgesics
• Antidepressants
• Antidiarrheal
• Antifungal
• Anti-histamines
• Anti-hypertensives
• Anti-metabolites
• Anti-neoplastic Antibiotics
• Antipyschotics
• Others
By Disorder/Disease
• Allergy and Respiratory
• Cancer
• Cardiovascular
• Central Nervous System
• Gastrointestinal
• Hormonal Imbalance
• Infections
• Others
By Services
• Child Psychiatry Services
• Gastrointestinal Services
• Pediatric Cancer Services
• Pediatric Diabetes Services
• Pediatric Heart Services
• Others
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10078919 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
